Journal
JOURNAL OF HUMAN HYPERTENSION
Volume 21, Issue 1, Pages 20-27Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/sj.jhh.1002101
Keywords
angiotensin II; angiotensin II receptor blockers; inflammation; oxidative stress; nuclear factor-kappa B; reactive oxygen species
Categories
Ask authors/readers for more resources
Angiotensin II (Ang II) increases adhesion molecules, cytokines and chemokines and exerts a proinflammatory effect on leucocytes, endothelial cells and vascular smooth muscle cells. Acting via the type 1 receptor, Ang II initiates an inflammatory cascade of reduced nicotinamideadenine dinucleotide phosphate oxidase, reactive oxygen species (ROS) and nuclear factor-kappa B, which mediates transcription and gene expression and increases adhesion molecules and chemokines. An excess of ROS decreases nitric oxide bioavailability, causes endothelial dysfunction, and promotes atherosclerosis. Moreover, Ang II interrupts the anti-inflammatory effects of insulin. Together, these effects promote a prothrombotic state as well as plaque rupture. Ang II receptor blockers suppress mediators of inflammation, including ROS and C-reactive protein, and they increase expression of inhibitory kappa B ( an inhibitor of nuclear factor-kappa B). These anti-inflammatory and antioxidative effects, which are probably due in part to unopposed stimulation of the Ang II type 2 receptor, may be beneficial in acute coronary syndromes and may also contribute to the prevention of type II diabetes mellitus, as insulin resistance is mediated by inflammatory processes.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available